Table 3 CMR characteristics for Control and PostC, long-term follow-up
Control, n=35 | PostC, n=33 | |||||
|---|---|---|---|---|---|---|
1 week | 3 months | 12 months | 1 week | 3 months | 12 months | |
LV end-diastolic volume index, ml/m 2 | 89 (80, 99) | 88 (77,103) | 86 (70, 104) | 79 (73, 84) | 85 (77, 99) | 79 (73, 91) |
LV end-systolic volume index, ml/m 2 | 49 (37, 56) | 44 (35, 58) | 39 (33, 57) | 43 (36, 55) | 43 (37, 55) | 40 (32, 48) |
Sphericity index, end-diastole | 0.39 (0.35, 0.42) | 0.39 (0.32, 0.47) | 0.38 (0.33, 0.44) | 0.38 (0.34, 0.45) | 0.40 (0.35, 0.44) | 0.37 (0.33, 0.44) |
LV-mass index, g/m 2 | 68 (60, 75) | 61 (55, 69)** | 60 (55, 67)***, # | 65 (59, 75) | 59 (56, 70)*** | 57 (54, 68)*** |
Infarct size, % of LV mass | 8.0 (5.5, 14.1) | 6.6 (4.3, 13.6)*** | 6.0 (4.3, 13.1)*** | 9.9 (5.5, 14.9) | 8.8 (5.0, 11.5)*** | 7.6 (4.9, 12.2)*** |
Infarct size, g | 12.3 (7.5, 23.8) | 9.1 (5.4, 21.1)*** | 7.8 (4.9, 19.8)***, ## | 11.2 (7.7, 25.5) | 10.1 (6.2, 18.8)*** | 10.6 (5.4, 16.9)*** |
Infarct size, % of ACS | 39 (27, 54) | 33 (21, 44)*** | 31 (23, 41)*** | 41 (26, 54) | 31 (22, 45)*** | 31 (23, 43)*** |
Microvascular obstruction (LGE), % of LV mass | 2.0 (1.4, 2.8) | - | - | 1.8 (1.1, 2.8) | - | - |